NCT00246324 Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00240032 A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. Status COMPLETED Phase PHASE4
NCT00240006 A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone Status COMPLETED Phase PHASE4
NCT00239993 A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® Status COMPLETED Phase PHASE4
NCT00238654 A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy Status COMPLETED Phase N/A
NCT00230204 Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis Status UNKNOWN Phase PHASE1
NCT00228228 TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis Status UNKNOWN Phase PHASE3
NCT00228163 Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses Status COMPLETED Phase PHASE2
NCT00223457 Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis Status COMPLETED Phase N/A
NCT00223301 Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT00220922 A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. Status COMPLETED Phase PHASE4
NCT00217295 A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis Status UNKNOWN Phase PHASE2
NCT00207727 A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00206635 Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase N/A
NCT00202410 Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT00202397 Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Status COMPLETED Phase PHASE2
NCT00202384 Gene Expression in MS Patients Before and During Treatment With Interferon-beta Status TERMINATED Phase N/A